News from nuvo pharmaceuticals inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 09, 2021, 07:30 ET Miravo Healthcare™ to Present at Upcoming Investor Conferences

• Bloom Burton & Co. Healthcare Investor Conference - April 21st at 10:00 a.m. EST • • Planet MicroCap Showcase - April 22nd at 10:00 a.m. EST •...

Mar 26, 2021, 10:00 ET Miravo Healthcare™ Acknowledged In The Globe and Mail's Second-Annual Women Lead Here Benchmark of Executive Gender Diversity

MISSISSAUGA, ON, March 26, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a ...

Mar 11, 2021, 07:30 ET Miravo Healthcare™ to Present at Q1 Virtual Investor Summit

- Wednesday, March 24th - 3:30 p.m. EST - MISSISSAUGA, ON, March 11, 2021 /PRNewswire/ - Nuvo Pharmaceuticals® Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a...

Mar 08, 2021, 17:00 ET Miravo Healthcare™ Files Preliminary Base Shelf Prospectus

MISSISSAUGA, ON, March 8, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare ("Miravo" or "the Company") ...

Mar 08, 2021, 07:30 ET Miravo Healthcare™ Announces 2020 and Fourth Quarter Results

- Fiscal Year 2020 Adjusted Total Revenue - $71.0 million - - Fiscal Year 2020 Adjusted EBITDA - $28.4 million - - Blexten Canadian Prescriptions...

Mar 01, 2021, 07:30 ET Miravo Healthcare™ Ireland Enters into Resultz® License and Supply Agreement with The Mentholatum Company for the United States

- Commercial launch anticipated in Summer 2021 - MISSISSAUGA, ON, March 1, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF)...

Feb 22, 2021, 07:30 ET Miravo Healthcare™ Announces Fourth Quarter 2020 Results Release Date and Conference Call Details

MISSISSAUGA, ON, Feb. 22, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a...

Jan 14, 2021, 07:30 ET Miravo Healthcare™ to Host Investor Webcast on January 28, 2021 at 2:00 p.m. EST

MISSISSAUGA, ON, Jan. 14, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a...

Jan 13, 2021, 07:30 ET Miravo Healthcare™ Announces the Canadian Commercial Launch of NeoVisc®+ and NeoVisc® ONE for the Treatment of Pain and Improvement of Joint Functionality of the Knee

MISSISSAUGA, ON, Jan. 13, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a...

Dec 21, 2020, 07:30 ET Miravo Healthcare™ Ireland Enters into Suvexx® License and Supply Agreement with Orion Corporation for Select EU Markets

- First European Partnering Deal for Suvexx - - Up to EUR 1.7 million in upfront and milestone payments - MISSISSAUGA, ON, Dec. 21, 2020 /PRNewswire/ ...

Dec 18, 2020, 07:30 ET Nuvo Pharmaceuticals® Announces Corporate Rebranding as Miravo Healthcare™

- Consolidates to One Single Corporate Brand Identity - MISSISSAUGA, ON, Dec. 18, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX:NRI)...

Nov 16, 2020, 07:30 ET Nuvo Pharmaceuticals® Announces Third Quarter 2020 Results

- Q3 2020 Adjusted Total Revenue - $16.7 million - - Q3 2020 Adjusted EBITDA - $6.6 million - - Blexten Canadian Prescriptions Increased 30%...

Nov 02, 2020, 07:30 ET Nuvo Pharmaceuticals™ Announces Third Quarter 2020 Results Release Date and Conference Call Details

MISSISSAUGA, ON, Nov. 2, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI) (OTCQX: NRIFF), a Canadian-focused healthcare ...

Oct 05, 2020, 07:30 ET Nuvo Pharmaceuticals® to Webcast Live at VirtualInvestorConferences.com October 8th

- Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on...

Sep 14, 2020, 07:30 ET Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum September 17th

- Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on...

Sep 09, 2020, 07:30 ET Nuvo Pharmaceuticals® Announces The Canadian Commercial Launch of Suvexx™ - For The Acute Treatment of Migraine

- Combination of sumatriptan succinate and naproxen sodium in a single tablet - MISSISSAUGA, ON, Sept. 9, 2020 /PRNewswire/ - Nuvo Pharmaceuticals...

Aug 10, 2020, 07:30 ET Nuvo Pharmaceuticals® Announces Second Quarter 2020 Results

٠ Q2 2020 Adjusted Total Revenue - $18.0 million ٠ ٠ Q2 2020 Adjusted EBITDA - $7.6 million ٠ ٠ Blexten Canadian Prescriptions Increased 34%...

Jul 27, 2020, 07:30 ET Nuvo Pharmaceuticals™ Announces Second Quarter 2020 Results Release Date and Conference Call Details

MISSISSAUGA, ON, July 27, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI) (OTCQX: NRIFF), a Canadian-focused...

May 12, 2020, 16:20 ET Nuvo Pharmaceuticals® Announces Director Election Results of its Annual & Special Meeting of Shareholders

MISSISSAUGA, ON, May 12, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI; OTCQX: NRIFF) a Canadian-focused healthcare...

May 11, 2020, 07:30 ET Nuvo Pharmaceuticals® Announces First Quarter 2020 Results

٠ Q1 2020 Adjusted Total Revenue - $18.9 million ٠ ٠ Q1 2020 Adjusted EBITDA - $8.0 million ٠ ٠ Blexten Canadian Prescriptions Increased 54%...

Apr 27, 2020, 07:30 ET Nuvo Pharmaceuticals® Announces First Quarter 2020 Results Release Date and Virtual Annual & Special Meeting of Shareholders

MISSISSAUGA, ON, April 27, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused, healthcare ...

Mar 31, 2020, 07:30 ET Nuvo Pharmaceuticals® Announces Approval of Takeda's Cabpirin Tablets in Japan, Triggering a US$2.0 Million Milestone Payment due in Q2 2020

- Takeda holds a non-exclusive license to Nuvo's Yosprala™ patent permitting it to market Capbirin in Japan - MISSISSAUGA, ON, March 31, 2020...

Mar 23, 2020, 10:00 ET Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum March 26th

- Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on...

Mar 04, 2020, 17:05 ET Nuvo Pharmaceuticals® Announces "at risk" Launch of Generic Version of Vimovo in the United States

MISSISSAUGA, ON, March 4, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused healthcare...

Feb 27, 2020, 17:05 ET Nuvo Pharmaceuticals® Announces Health Canada Approves Suvexx™ For The Acute Treatment of Migraine

- Canadian Launch Anticipated in the Second Half of 2020 - MISSISSAUGA, ON, Feb. 27, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the...